Clinical Trials Logo

Filter by:
NCT ID: NCT06335511 Recruiting - Clinical trials for Lumbar Spinal Stenosis

Decompression Versus Instrumented Fusion for Lumbar Degenerative Disease. Clinical and Biomechanical Outcome Study

ARCHIMEDE
Start date: October 10, 2022
Phase:
Study type: Observational

Identification of clinical and instrumental parameters that could predict the outcome of surgical decompression of lumbar degenerative stenosis.

NCT ID: NCT06335342 Recruiting - Clinical trials for Head and Neck Neoplasms

Radiotherapy Treatments for Neoplasms in the Head and Neck Region

Start date: February 22, 2018
Phase:
Study type: Observational

The aim of this study is the evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of radiotherapy treatments in the head and neck region. Eligible patients undergoing radiotherapy for primary or secondary neoplasms localized in the head and neck anatomical region.

NCT ID: NCT06335290 Recruiting - Thoracic Neoplasms Clinical Trials

Radiotherapy Treatments for the Treatment of Thoracic District Tumors

Start date: February 22, 2018
Phase:
Study type: Observational

Evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of thoracic radiotherapy treatments in patients undergoing radiotherapy for primary or secondary neoplasms localized in the thoracic anatomical region.

NCT ID: NCT06335277 Recruiting - Lymphoma Clinical Trials

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Start date: February 22, 2018
Phase:
Study type: Observational

Patients eligible undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplant.

NCT ID: NCT06335251 Recruiting - Bone Metastases Clinical Trials

Radiotherapy Treatments for Neoplasms of the Limbs

Start date: February 22, 2018
Phase:
Study type: Observational

In this observational study patients treated at European Institute of Oncology with radiotherapy to limbs will be included

NCT ID: NCT06335238 Recruiting - Abdominal Cancer Clinical Trials

Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region

Start date: February 22, 2018
Phase:
Study type: Observational

Evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of abdominal-pelvic region radiotherapy treatments in patients undergoing radiotherapy for primary or secondary neoplasms localized in the tabdominal-pelvic region.

NCT ID: NCT06335173 Recruiting - Alzheimer Disease Clinical Trials

A Study to Evaluate Efficacy and Safety of Intravenous ACU193 in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

ALTITUDE-AD
Start date: February 29, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the efficacy of ACU193 infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.

NCT ID: NCT06335030 Recruiting - Clinical trials for Autism Spectrum Disorder

Sensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With Autism

Start date: March 29, 2021
Phase:
Study type: Observational [Patient Registry]

Brief Summary: Eating problems and in particular food selectivity is a condition that worsens a long-life disorder such as Autism Spectrum Disorder (ASD) , both on an individual level, both on family and social ones . Children (2-6 years) diagnosed with ASD according to Diagnostic and Statistical Manual of Mental Disorders 5 Edition (DSM5) criteria were enrolled in an observational, cross-sectional and multicentric study conducted by three different Italian clinical centers. Regarding this sample, principal aims of the study are to describe characteristics of food selectivity, to evaluate its correlation with ASD symptoms, with cognitive and adaptive functioning of ASD preschoolers, to describe its impact on parental stress.

NCT ID: NCT06335004 Active, not recruiting - Pediatric Disorder Clinical Trials

Evaluation of Brain Waste Clearance Pathways Using Magnetic Resonance Imaging in Pediatric Patients With White Matter Diseases

Start date: March 1, 2022
Phase:
Study type: Observational

The dilation of perivascular spaces can be the result of various etiopathogenetic processes. White matter atrophy can cause enlargement of these perivascular spaces (PVS) but also obstruction of fluid drainage systems (interstitial fluid, ISF) and metabolites, as evidenced by some recent studies. Focal stagnation of liquids and deposition of toxic material induce tissue hypoxia and neuroglial dysfunction. Dilation of PVS can be associated with changes in white matter and microhemorrhages. We want to study these etiopathogenetic phenomena by implementing specific MRI methods.

NCT ID: NCT06334861 Recruiting - Herpes Zoster Clinical Trials

Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage

CeVOT-Her-Zo
Start date: June 23, 2022
Phase:
Study type: Observational

The National Vaccination Program, updated by the Ministry of Health in 2021, provides a new vaccination opportunity for frail patients against Herpes zoster virus (HZ). The new treatment option, on the other hand, is designed by combining VZV-specific antigen (gE) with an adjuvant system (AS01B) to induce antigen-specific cellular and humoral immune responses in individuals with preexisting immunity to VZV. Efficacy, assessed in people given two doses 2 months apart, is around 97% in those aged 50 years and 91% in those over 70 years. In the studies conducted, HZ-related hospitalizations were significantly reduced. The vaccine schedule calls for the administration of two doses 2 months apart. The current HZ Vaccination Program implemented at the regional level recommends its active and free offer in people from 18 years of age with congenital and/or acquired immunodepression, through a collaborative relationship involving, on the one hand, multispecialist and multiprofessional medical staff and, on the other hand, citizens called to play a role that is no longer passive but the subject of empowerment by consciously making their own health choices. The collaboration with ASL Roma1, in this sense, acquires value as guarantor of the supply of the adjuvanted recombinant anti-HZ vaccine and of the appropriate reporting of vaccination coverage, which to date is still far from the targets set by the PNPV'17-'19 in adults at risk for disease. The purpose of this study Single-center prospective longitudinal observational cohort study is to verify patients' compliance with the proposed vaccination, the effectiveness of counseling carried out by a multidisciplinary team in the hospital setting.